O3‐04–05: Clinical trials of bapineuzumab, a beta‐amyloid‐targeted immunotherapy in patients with mild to moderate Alzheimer's disease
Year: 2008
Type: article
Source: Alzheimer s & Dementia
Authors: Michael Grundman, Ronald Black
Institutions: Elan Pharmaceuticals, Inc. (Ireland), Wyeth
Language: English
Subfield: Cellular and Molecular Neuroscience
Field: Neuroscience
Domain: Life Sciences
Keywords: bapineuzumab, Alzheimer's disease
Open Access status: closed
OpenAlex ID: W2079845730
